Previously, berberine enhanced the sensitivity of MCF-7-resistant breast cancer cells toward tamoxifen; however, its molecular mechanism still remains unclear. The purpose of this study is to identify the potential targets and molecular mechanism of berberine in overcoming breast cancer resistance toward tamoxifen by using a bioinformatics approach for functional network analysis. The microarray data of tamoxifen-resistant and berberine-treated MCF-7 cells were obtained from GSE67916 and GSE85871, which resulted in differentially expressed genes (DEGs). The analysis of Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment by using The Database for Annotation, Visualization and Integrated Discovery (DAVID) revealed that several DEGs participated in the erbB tyrosine kinase signaling pathway. The analysis of proteinprotein interaction network and hub genes selection by using STRING and Cytoscape identified the top 10 genes with the highest degree score. The analysis of genetic alterations by using cBioportal demonstrated genetic alterations of six potential target genes including PRKCA, EGFR, ERBB4, AREG, ESR1, and STAT1. Moreover, importantly, the erbB signaling is a potential target for overcoming breast cancer resistance toward tamoxifen. Further studies are required to validate the results of this study.
Key words: berberine, tamoxifen resistance, breast cancer, functional network, bioinformatics
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
We use cookies and other tracking technologies to work properly, to analyze our website traffic, and to understand where our visitors are coming from. More InfoGot It!
